BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hokari A, Ishikawa T, Tajiri H, Matsuda T, Ishii O, Matsumoto N, Okuse C, Takahashi H, Kurihara T, Kawahara KI, Maruyama I, Zeniya M. Efficacy of MK615 for the treatment of patients with liver disorders. World J Gastroenterol 2012; 18(31): 4118-4126 [PMID: 22919243 DOI: 10.3748/wjg.v18.i31.4118]
URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4118.htm
Number Citing Articles
1
Masashi Yanaki, Masayuki Kobayashi, Atsushi Aruga, Minoru Nomura, Makoto Ozaki. In Vivo Antitumor Effects of MK615 Led by PD-L1 DownregulationIntegrative Cancer Therapies 2018; 17(3): 646 doi: 10.1177/1534735418766403
2
Takashi Hoshino, Hitoshi Takagi, Atsushi Naganuma, Eri Koitabashi, Sanae Uehara, Naomi Sakamoto, Tomohiro Kudo, Ken Sato, Satoru Kakizaki. Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot &ldquo;<italic>Prunus mume</italic>&rdquo;World Journal of Hepatology 2013; 5(10): 596-600 doi: 10.4254/wjh.v5.i10.596
3
Katsuya Hiraishi, Fumie Jimma, Hiroyuki Soma, Tomohiro Kagawa, Ippei Yamaoka. Investigating a novel hepatoprotective substance from ume extract (heated Japanese apricot juice concentrate). Part 2: Elucidation of chemical structureNFS Journal 2022; 26: 33 doi: 10.1016/j.nfs.2021.05.002
4
Katsuya Hiraishi, Fumie Jimma, Hiroyuki Soma, Tomohiro Kagawa, Ippei Yamaoka. Investigating a novel hepatoprotective substance from ume extract (heated Japanese apricot juice concentrate). Part 1: Finding an active substance using a liver injury rat modelNFS Journal 2022; 26: 22 doi: 10.1016/j.nfs.2021.05.003
5
Jianxing Luo, Yang Zhang, Xiaoyu Hu, Sen Zhong, Guo Chen, Yanyan Wang, Wu Lin, Cheng Yi, Hong Zhu. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by d-galactosamine in ratsJournal of Ethnopharmacology 2015; 161: 53 doi: 10.1016/j.jep.2014.12.003
6
Alberto Beretta, Roberto Accinni, Cinzia Dellanoce, Annamaria Tonini, Jean-Michel Cardot, Anthony Bussière. Efficacy of a Standardized Extract ofPrunus mumein Liver Protection and Redox Homeostasis: A Randomized, Double-Blind, Placebo-Controlled StudyPhytotherapy Research 2016; 30(6): 949 doi: 10.1002/ptr.5597
7
Hye-jin Yoon, Bong Soo Cha. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2014; 6(11): 800-811 doi: 10.4254/wjh.v6.i11.800
8
Eleftheria C. Sagiadinou, Eleni A. Karavia, Eva Xepapadaki, Evangelia Zvintzou, Aikaterini Hatziri, Dimitra-Sotiria Karampela, Panagiota C. Giannopoulou, Dionysios J. Papachristou, George Panayiotakopoulos, Kyriakos E. Kypreos. Benefits of a fixed-dose combination of standardized P. mume extract with choline on adipose tissue mitochondrial metabolic activity and pancreatic β-islet secretory capacity in micePhytomedicine Plus 2022; 2(3): 100317 doi: 10.1016/j.phyplu.2022.100317
9
Christian Bailly. Anticancer properties of Prunus mume extracts (Chinese plum, Japanese apricot)Journal of Ethnopharmacology 2020; 246: 112215 doi: 10.1016/j.jep.2019.112215
10
Nazish Butt, Muhammad Masood, Aamir Ali. Efficacy and Safety of Prunus mume and Choline in Patients with Nonalcoholic Fatty Liver DiseaseEuroasian journal of hepato-gastroenterology 2023; 13(2): 124 doi: 10.5005/jp-journals-10018-1397
11
Ming Hong, Sha Li, Hor Tan, Ning Wang, Sai-Wah Tsao, Yibin Feng. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future ProspectsInternational Journal of Molecular Sciences 2015; 16(12): 28705 doi: 10.3390/ijms161226126
12
Juan Zheng, Ting Chen, Xin Guo, James M. Ntambi, Chaodong Wu. Lipid Signaling and Metabolism2020; : 273 doi: 10.1016/B978-0-12-819404-1.00014-2
13
Xue-Peng Gong, Ying Tang, Yuan-Yuan Song, Guang Du, Juan Li. Comprehensive Review of Phytochemical Constituents, Pharmacological Properties, and Clinical Applications of Prunus mumeFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.679378